Real-time enrollment status for this recurrent multiple myeloma clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 7:47 AM UTC
| NCT Number | NCT05847569 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Multiple Myeloma |
| Phase | PHASE2 |
| Target Enrollment | 62 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | July 14, 2026 (Jul 14, 2026) |
As of August 29, 2026: Clinical trial NCT05847569 is currently recruiting participants. This phase2 study for recurrent multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05847569 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05847569 was last updated Jul 14, 2026 (July 14, 2026). HelloStudys verifies this status automatically.